Closer look at four of our recommendations

Article Excerpt

Here’s a look at some of the factors that make the three ETFs we see as buys on pages 3 and 4 attractive—and why we don’t like the fourth. Healthy profits in healthcare equipment With the onset of the COVID-19 pandemic, healthcare equipment providers were hurt as hospitals prioritized emergency care over non-critical procedures. But the long-term trends that favoured the medical equipment suppliers have since resumed. The top U.S.-based medical equipment companies—including Abbott Laboratories, Medtronic, and Stryker—have high research and development costs and face the risk of product failure. However, their products typically have long shelf lives once they have been approved by the regulators and accepted by medical practitioners. The iShares U.S. Medical Devices ETF is a buy. Commodity producers for portfolio balance A key tenet of our TSI investment philosophy is the diversification of investment portfolio holdings among the five main economic sectors—and that includes Resources & Commodities. Many resource prices softened in 2023. That’s mostly on concerns that further interest rate increases could…